Quantum-Si incorporated QSIAW

Competitive advantage analysis · healthcare

Medical Devices & Diagnostics
Overall moat score
49/100
Developing

About Quantum-Si incorporated

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid … Full QSIAW analysis →

Competitive advantage assessment

Key strengths

  • Durable Capital Returns ROIC durability is strong (score 0.69). Consistent returns confirm the moat is not eroding.
  • Improving FCF Trend FCF trend score is positive (score 1.00). Improving FCF margin signals compounding operational leverage.

Key risks

  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.34). May indicate commodity-like product mix or distributor margin drag.
  • Weak FCF Generation FCF margin quality lags peers (score 0.08). Below-peer FCF conversion is a MedTech quality warning.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
43

Where QSIAW ranks in Medical Devices

Quantum-Si incorporated ranks #75 of 160 scored companies in Medical Devices by moat score — the top 47%. The widest moat in the group is iRadimed Corporation (IRMD) at 83/100.

Moat scores for companies ranked near QSIAW in Medical Devices
# Company Moat score Rating
71 Avita Medical, Inc. RCEL 50/100 Moderate
72 Glaukos Corporation GKOS 50/100 Moderate
73 908 Devices Inc. MASS 49/100 Developing
74 Quantum-Si Incorporated QSI 49/100 Developing
75 Quantum-Si incorporated QSIAW 49/100 Developing
76 Owlet, Inc. OWLT 49/100 Developing
77 CVRx, Inc. CVRX 49/100 Developing
78 Profound Medical Corp. PROF 49/100 Developing
79 Butterfly Network, Inc. BFLY 49/100 Developing

See every Medical Devices & Diagnostics company ranked by moat score →

How QSIAW scores on the Medical Devices & Diagnostics defenses

Pricing Power & Consumable Moat

Score 43 · 25% of the moat score

In MedTech, pricing power is rarely about the machine — it is about what the machine consumes.

R&D Pipeline & Capital Returns

Score 53 · 20% of the moat score

Research spending is how a device company keeps its installed base current, but spending alone proves nothing.

FCF Quality & Cash Conversion

Score 50 · 20% of the moat score

MedTech companies grow by acquisition, and the resulting intangible amortisation depresses reported earnings without consuming any cash.

Commercial Execution

Score 46 · 15% of the moat score

Devices are sold into hospitals and labs through committees, tenders and long qualification cycles, which makes the sales organisation expensive and hard to replicate.

Capital Structure & Resilience

Score 78 · 12% of the moat score

Serial acquirers carry debt, and the question is whether the cash flows underneath it are dependable enough to service it through a downturn.

Growth Durability

Score 38 · 8% of the moat score

Growth durability separates an expanding installed base from a good product cycle.

How each Medical Devices & Diagnostics defense is measured, in full →

Understanding QSIAW's moat

What is Quantum-Si incorporated's moat score?

Quantum-Si incorporated (QSIAW) scores 49 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as developing. It ranks #75 of 160 scored companies in Medical Devices, the top 47%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 159 companies in Medical Devices. Its strongest defense is Capital Structure & Resilience (78/100) and its weakest is Growth Durability (38/100).

How does Quantum-Si incorporated compare with other Medical Devices companies?

Quantum-Si incorporated ranks #75 of 160 scored companies in Medical Devices by moat score. The widest moat in Medical Devices is iRadimed Corporation (IRMD) at 83/100. The companies ranked closest are Quantum-Si Incorporated (QSI) at 49 just above it and Owlet, Inc. (OWLT) at 49 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Medical Devices & Diagnostics in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 159 companies in Medical Devices. The defenses are then weighted to produce the overall score out of 100.

Why is Quantum-Si incorporated scored with the Medical Devices & Diagnostics template?

Medical device and diagnostics companies place an instrument once and then sell the consumables, reagents and service that instrument needs for the next decade. The economics are a razor-and-blade model wrapped in regulatory approval and clinician habit, so the MedTech template scores the durability of that installed base rather than the size of any single product launch.

Which competitive defenses are measured for Quantum-Si incorporated?

The Medical Devices & Diagnostics template measures 6 defenses, and QSIAW scores: Pricing Power & Consumable Moat (43), R&D Pipeline & Capital Returns (53), FCF Quality & Cash Conversion (50), Commercial Execution (46), Capital Structure & Resilience (78), Growth Durability (38). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000